US8124618B2
(en)
|
1998-12-11 |
2012-02-28 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8084462B2
(en)
|
1998-12-11 |
2011-12-27 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8124619B2
(en)
|
1998-12-11 |
2012-02-28 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US7425561B2
(en)
|
1998-12-11 |
2008-09-16 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US7754189B2
(en)
|
1998-12-11 |
2010-07-13 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US7767193B2
(en)
|
1998-12-11 |
2010-08-03 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8124620B2
(en)
|
1998-12-11 |
2012-02-28 |
Targacept, Inc. |
3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8158649B2
(en)
|
2003-02-21 |
2012-04-17 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8143272B2
(en)
|
2003-02-21 |
2012-03-27 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
AU2004215386B2
(en)
*
|
2003-02-21 |
2009-06-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US8541447B2
(en)
|
2003-02-21 |
2013-09-24 |
Targacept, Inc. |
3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
|
EA011033B1
(ru)
*
|
2003-02-21 |
2008-12-30 |
Таргасепт, Инк. |
3-замещенные-2(арилалкил)-1-азабициклоалканы и способы их применения
|
US8846715B2
(en)
|
2007-08-02 |
2014-09-30 |
Targacept, Inc. |
(2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof
|
US7981906B2
(en)
|
2007-08-02 |
2011-07-19 |
Targacept, Inc. |
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
|
US8541446B2
(en)
|
2007-08-02 |
2013-09-24 |
Targacept, Inc. |
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
|
US8119659B2
(en)
|
2007-08-02 |
2012-02-21 |
Targacept, Inc. |
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
|
US8476296B2
(en)
|
2009-01-26 |
2013-07-02 |
Targacept, Inc. |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
|
US8901151B2
(en)
|
2009-01-26 |
2014-12-02 |
Targacept, Inc. |
Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|